Prescient Healthcare Group, a UK-based product strategy consultancy to the global biopharmaceutical industry, has acquired London-based pricing and market access consultancy Dolon, strengthening its ability to support global biopharma companies navigating increasingly complex and interconnected clinical, commercial and market access environments.
The deal enhances the breadth of Prescient’s offer to the...
LBB, a UK-based independent latent defects insurance (LDI) and construction bond specialist consultancy, has successfully placed a consolidated latent defects insurance (LDI) programme totalling £1.16m in premiums, supporting the acquisition of a group of care home developments across the UK by a major international healthcare real estate investor.
The total sum insured for the project was £92.7m, with individual cover levels structured across the owning entities.
The buyer, a leading healthcare real estate investment trust (REIT), required comprehensive LDI coverage due to the scale of the investment, the development stage of...